Different levels of skin whitening activity among 3,6-anhydro-L-galactose, agarooligosaccharides, and neoagarooligosaccharides

Ji Hye Kim, Eun Ju Yun, Sora Yu, Kyoung Heon Kim, Nam Joo Kang

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

3,6-Anhydro-L-galactose (AHG), a major monomeric constituent of red macroalgae (Rhodophyta), was recently reported to possess skin whitening activity. Moreover, AHG-containing oligosaccharides, such as agarooligosaccharides (AOSs) and neoagarooligosaccharides (NAOSs), have various physiological activities, including anti-inflammatory, antioxidant, and skin moisturizing effects. In this study, AHG and NAOSs were produced from agarose by enzymatic reactions catalyzed by an endo-type β-agarase, an exo-type β-agarase, and a neoagarobiose hydrolase. In a cell proliferation assay, AHG, AOSs, and NAOSs at 12.5, 25, and 50 µg/mL concentrations did not exhibit cytotoxicity toward murine B16 melanoma cells or human epidermal melanocytes. In an in vitro skin whitening activity assay of AHG, AOSs, and NAOSs at 50 µg/mL, AHG showed the highest skin whitening activity in both murine B16 melanoma cells and human epidermal melanocytes; this activity was mediated by the inhibition of melanogenesis. Neoagarotetraose and neoagarohexaose also exhibited in vitro skin whitening activity, whereas neoagarobiose and AOSs with degrees of polymerization of 3 (agarotriose), 5 (agaropentaose), and 7 (agaroheptaose) did not. Therefore, AHG is responsible for the skin whitening activity of agar-derived sugars, and the structural differences among the AHG-containing oligosaccharides may be responsible for their different skin whitening activities.

Original languageEnglish
Article number321
JournalMarine Drugs
Volume15
Issue number10
DOIs
Publication statusPublished - 2017 Oct 1

Fingerprint

Galactose
Skin
Experimental Melanomas
Melanocytes
Oligosaccharides
Rhodophyta
Seaweed
Polymerization
Sepharose
Agar
Anti-Inflammatory Agents
Antioxidants
Cell Proliferation

Keywords

  • 3,6-anhydro-L-galactose
  • Agarooligosaccharides
  • Melanogenesis
  • Neoagarooligosaccharides
  • Skin whitening
  • α-melanocyte-stimulating hormone

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Different levels of skin whitening activity among 3,6-anhydro-L-galactose, agarooligosaccharides, and neoagarooligosaccharides. / Kim, Ji Hye; Yun, Eun Ju; Yu, Sora; Kim, Kyoung Heon; Kang, Nam Joo.

In: Marine Drugs, Vol. 15, No. 10, 321, 01.10.2017.

Research output: Contribution to journalArticle

@article{26ee55f49d1943b3a6aefa67993f7e83,
title = "Different levels of skin whitening activity among 3,6-anhydro-L-galactose, agarooligosaccharides, and neoagarooligosaccharides",
abstract = "3,6-Anhydro-L-galactose (AHG), a major monomeric constituent of red macroalgae (Rhodophyta), was recently reported to possess skin whitening activity. Moreover, AHG-containing oligosaccharides, such as agarooligosaccharides (AOSs) and neoagarooligosaccharides (NAOSs), have various physiological activities, including anti-inflammatory, antioxidant, and skin moisturizing effects. In this study, AHG and NAOSs were produced from agarose by enzymatic reactions catalyzed by an endo-type β-agarase, an exo-type β-agarase, and a neoagarobiose hydrolase. In a cell proliferation assay, AHG, AOSs, and NAOSs at 12.5, 25, and 50 µg/mL concentrations did not exhibit cytotoxicity toward murine B16 melanoma cells or human epidermal melanocytes. In an in vitro skin whitening activity assay of AHG, AOSs, and NAOSs at 50 µg/mL, AHG showed the highest skin whitening activity in both murine B16 melanoma cells and human epidermal melanocytes; this activity was mediated by the inhibition of melanogenesis. Neoagarotetraose and neoagarohexaose also exhibited in vitro skin whitening activity, whereas neoagarobiose and AOSs with degrees of polymerization of 3 (agarotriose), 5 (agaropentaose), and 7 (agaroheptaose) did not. Therefore, AHG is responsible for the skin whitening activity of agar-derived sugars, and the structural differences among the AHG-containing oligosaccharides may be responsible for their different skin whitening activities.",
keywords = "3,6-anhydro-L-galactose, Agarooligosaccharides, Melanogenesis, Neoagarooligosaccharides, Skin whitening, α-melanocyte-stimulating hormone",
author = "Kim, {Ji Hye} and Yun, {Eun Ju} and Sora Yu and Kim, {Kyoung Heon} and Kang, {Nam Joo}",
year = "2017",
month = "10",
day = "1",
doi = "10.3390/md15100321",
language = "English",
volume = "15",
journal = "Marine Drugs",
issn = "1660-3397",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "10",

}

TY - JOUR

T1 - Different levels of skin whitening activity among 3,6-anhydro-L-galactose, agarooligosaccharides, and neoagarooligosaccharides

AU - Kim, Ji Hye

AU - Yun, Eun Ju

AU - Yu, Sora

AU - Kim, Kyoung Heon

AU - Kang, Nam Joo

PY - 2017/10/1

Y1 - 2017/10/1

N2 - 3,6-Anhydro-L-galactose (AHG), a major monomeric constituent of red macroalgae (Rhodophyta), was recently reported to possess skin whitening activity. Moreover, AHG-containing oligosaccharides, such as agarooligosaccharides (AOSs) and neoagarooligosaccharides (NAOSs), have various physiological activities, including anti-inflammatory, antioxidant, and skin moisturizing effects. In this study, AHG and NAOSs were produced from agarose by enzymatic reactions catalyzed by an endo-type β-agarase, an exo-type β-agarase, and a neoagarobiose hydrolase. In a cell proliferation assay, AHG, AOSs, and NAOSs at 12.5, 25, and 50 µg/mL concentrations did not exhibit cytotoxicity toward murine B16 melanoma cells or human epidermal melanocytes. In an in vitro skin whitening activity assay of AHG, AOSs, and NAOSs at 50 µg/mL, AHG showed the highest skin whitening activity in both murine B16 melanoma cells and human epidermal melanocytes; this activity was mediated by the inhibition of melanogenesis. Neoagarotetraose and neoagarohexaose also exhibited in vitro skin whitening activity, whereas neoagarobiose and AOSs with degrees of polymerization of 3 (agarotriose), 5 (agaropentaose), and 7 (agaroheptaose) did not. Therefore, AHG is responsible for the skin whitening activity of agar-derived sugars, and the structural differences among the AHG-containing oligosaccharides may be responsible for their different skin whitening activities.

AB - 3,6-Anhydro-L-galactose (AHG), a major monomeric constituent of red macroalgae (Rhodophyta), was recently reported to possess skin whitening activity. Moreover, AHG-containing oligosaccharides, such as agarooligosaccharides (AOSs) and neoagarooligosaccharides (NAOSs), have various physiological activities, including anti-inflammatory, antioxidant, and skin moisturizing effects. In this study, AHG and NAOSs were produced from agarose by enzymatic reactions catalyzed by an endo-type β-agarase, an exo-type β-agarase, and a neoagarobiose hydrolase. In a cell proliferation assay, AHG, AOSs, and NAOSs at 12.5, 25, and 50 µg/mL concentrations did not exhibit cytotoxicity toward murine B16 melanoma cells or human epidermal melanocytes. In an in vitro skin whitening activity assay of AHG, AOSs, and NAOSs at 50 µg/mL, AHG showed the highest skin whitening activity in both murine B16 melanoma cells and human epidermal melanocytes; this activity was mediated by the inhibition of melanogenesis. Neoagarotetraose and neoagarohexaose also exhibited in vitro skin whitening activity, whereas neoagarobiose and AOSs with degrees of polymerization of 3 (agarotriose), 5 (agaropentaose), and 7 (agaroheptaose) did not. Therefore, AHG is responsible for the skin whitening activity of agar-derived sugars, and the structural differences among the AHG-containing oligosaccharides may be responsible for their different skin whitening activities.

KW - 3,6-anhydro-L-galactose

KW - Agarooligosaccharides

KW - Melanogenesis

KW - Neoagarooligosaccharides

KW - Skin whitening

KW - α-melanocyte-stimulating hormone

UR - http://www.scopus.com/inward/record.url?scp=85032939621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032939621&partnerID=8YFLogxK

U2 - 10.3390/md15100321

DO - 10.3390/md15100321

M3 - Article

C2 - 29053566

AN - SCOPUS:85032939621

VL - 15

JO - Marine Drugs

JF - Marine Drugs

SN - 1660-3397

IS - 10

M1 - 321

ER -